Adaptive Biotechnologies Corp
XBER:1HM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Adaptive Biotechnologies Corp
XBER:1HM
|
US |
|
B
|
Bank of Georgia Group PLC
F:GEB
|
UK |
|
Coca-Cola Bottlers Japan Holdings Inc
OTC:CCOJF
|
JP |
|
Agrana Beteiligungs AG
F:AGB2
|
AT |
|
Lords Group Trading PLC
LSE:LORD
|
UK |
|
Solteq Oyj
F:B3M
|
FI |
|
Galectin Therapeutics Inc
NASDAQ:GALT
|
US |
Wall St Price Targets
1HM Price Targets Summary
Adaptive Biotechnologies Corp
According to Wall Street analysts, the average 1-year price target for 1HM is 50.28 EUR with a low forecast of 43.71 EUR and a high forecast of 55.54 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1HM's stock price target?
Price Target
50.28
EUR
According to Wall Street analysts, the average 1-year price target for 1HM is 50.28 EUR with a low forecast of 43.71 EUR and a high forecast of 55.54 EUR.
What is the Revenue forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 5 years is 19%.
What is the Gross Profit forecast for Adaptive Biotechnologies Corp?
Projected CAGR
19%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 28%. The projected CAGR for the next 5 years is 19%.
